Daniel Boring

730 total citations
24 papers, 575 citations indexed

About

Daniel Boring is a scholar working on Pharmacology, Biochemistry and Molecular Biology. According to data from OpenAlex, Daniel Boring has authored 24 papers receiving a total of 575 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pharmacology, 7 papers in Biochemistry and 6 papers in Molecular Biology. Recurrent topics in Daniel Boring's work include Inflammatory mediators and NSAID effects (9 papers), Eicosanoids and Hypertension Pharmacology (5 papers) and Sulfur Compounds in Biology (4 papers). Daniel Boring is often cited by papers focused on Inflammatory mediators and NSAID effects (9 papers), Eicosanoids and Hypertension Pharmacology (5 papers) and Sulfur Compounds in Biology (4 papers). Daniel Boring collaborates with scholars based in United States, Canada and Pakistan. Daniel Boring's co-authors include Mitali Chattopadhyay, Ravinder Kodela, Khosrow Kashfi, Niharika Nath, Carlos A. Velázquez‐Martínez, Yosef Dastagirzada, Ronald A. Lubet, Clinton J. Grubbs, Vernon E. Steele and M. Margaret Juliana and has published in prestigious journals such as Cancer Research, Journal of Medicinal Chemistry and The Journal of Organic Chemistry.

In The Last Decade

Daniel Boring

24 papers receiving 566 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniel Boring United States 14 185 185 128 71 70 24 575
Carlos A. Velázquez‐Martínez Canada 16 276 1.5× 204 1.1× 111 0.9× 163 2.3× 58 0.8× 28 677
Giulia Nesi Italy 12 218 1.2× 204 1.1× 57 0.4× 110 1.5× 69 1.0× 16 550
L.J. Marnett United States 14 305 1.6× 92 0.5× 320 2.5× 118 1.7× 41 0.6× 19 737
Chuan Ji United States 13 456 2.5× 118 0.6× 252 2.0× 112 1.6× 55 0.8× 23 872
Thorsten J. Maier Germany 14 247 1.3× 93 0.5× 190 1.5× 64 0.9× 57 0.8× 24 670
Isabel Siegle Germany 11 172 0.9× 99 0.5× 183 1.4× 26 0.4× 84 1.2× 19 543
Michelle V. Williams United States 12 404 2.2× 158 0.9× 90 0.7× 66 0.9× 91 1.3× 14 729
Xiaoming Xin China 15 273 1.5× 241 1.3× 44 0.3× 33 0.5× 69 1.0× 24 701
Marc Lecomte France 12 212 1.1× 65 0.4× 164 1.3× 101 1.4× 31 0.4× 21 758
Weijian Zhang China 11 330 1.8× 306 1.7× 53 0.4× 33 0.5× 164 2.3× 18 839

Countries citing papers authored by Daniel Boring

Since Specialization
Citations

This map shows the geographic impact of Daniel Boring's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Boring with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Boring more than expected).

Fields of papers citing papers by Daniel Boring

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Boring. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Boring. The network helps show where Daniel Boring may publish in the future.

Co-authorship network of co-authors of Daniel Boring

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel Boring. A scholar is included among the top collaborators of Daniel Boring based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel Boring. Daniel Boring is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lubet, Ronald A., James M. Scheiman, Ann M. Bode, et al.. (2015). Prevention of Chemically Induced Urinary Bladder Cancers by Naproxen: Protocols to Reduce Gastric Toxicity in Humans Do Not Alter Preventive Efficacy. Cancer Prevention Research. 8(4). 296–302. 13 indexed citations
2.
Nicastro, Holly L., Clinton J. Grubbs, M. Margaret Juliana, et al.. (2013). Preventive Effects of NSAIDs, NO-NSAIDs, and NSAIDs Plus Difluoromethylornithine in a Chemically Induced Urinary Bladder Cancer Model. Cancer Prevention Research. 7(2). 246–254. 20 indexed citations
3.
Reid, Joel M., Chad A. Walden, Rui Qin, et al.. (2011). Phase 0 Clinical Chemoprevention Trial of the Akt Inhibitor SR13668. Cancer Prevention Research. 4(3). 347–353. 16 indexed citations
4.
Chattopadhyay, Mitali, et al.. (2011). Hydrogen sulfide-releasing aspirin suppresses NF-κB signaling in estrogen receptor negative breast cancer cells in vitro and in vivo. Biochemical Pharmacology. 83(6). 723–732. 88 indexed citations
5.
Kodela, Ravinder, Mitali Chattopadhyay, Niharika Nath, et al.. (2011). Synthesis and biological activity of acetyl-protected hydroxybenzyl diethyl phosphates (EHBP) as potential chemotherapeutic agents. Bioorganic & Medicinal Chemistry Letters. 21(23). 7146–7150. 4 indexed citations
6.
Chattopadhyay, Mitali, Ravinder Kodela, Niharika Nath, et al.. (2011). Hydrogen sulfide-releasing NSAIDs inhibit the growth of human cancer cells: A general property and evidence of a tissue type-independent effect. Biochemical Pharmacology. 83(6). 715–722. 109 indexed citations
7.
Chattopadhyay, Mitali, Ravinder Kodela, Niharika Nath, et al.. (2011). Hydrogen sulfide-releasing aspirin modulates xenobiotic metabolizing enzymes in vitro and in vivo. Biochemical Pharmacology. 83(6). 733–740. 29 indexed citations
8.
Chattopadhyay, Mitali, et al.. (2011). Abstract 4608: Hydrogen sulfide-releasing aspirin inhibits the growth of leukemic Jurkat cells and modulates β-catenin expression. Cancer Research. 71(8_Supplement). 4608–4608. 12 indexed citations
9.
Chattopadhyay, Mitali, et al.. (2011). Abstract 1349: Hydrogen sulfide-releasing aspirin suppresses NF-κB signaling in estrogen receptor negative breast cancer cells in vitro and in vivo. Cancer Research. 71(8_Supplement). 1349–1349. 1 indexed citations
10.
Nath, Niharika, Mitali Chattopadhyay, Ravinder Kodela, et al.. (2010). Modulation of stress genes expression profile by nitric oxide-releasing aspirin in Jurkat T leukemia cells. Biochemical Pharmacology. 79(12). 1759–1771. 5 indexed citations
11.
Chattopadhyay, Mitali, Satindra Goswami, Ravinder Kodela, et al.. (2010). NO-releasing NSAIDs suppress NF-κB signaling in vitro and in vivo through S-nitrosylation. Cancer Letters. 298(2). 204–211. 42 indexed citations
12.
Lubet, Ronald A., Daniel Boring, Vernon E. Steele, et al.. (2009). Lack of Efficacy of the Statins Atorvastatin and Lovastatin in Rodent Mammary Carcinogenesis. Cancer Prevention Research. 2(2). 161–167. 29 indexed citations
13.
Steele, Vernon E., Chinthalapally V. Rao, Yuting Zhang, et al.. (2009). Chemopreventive Efficacy of Naproxen and Nitric Oxide–naproxen in Rodent Models of Colon, Urinary Bladder, and Mammary Cancers. Cancer Prevention Research. 2(11). 951–956. 45 indexed citations
14.
Kodela, Ravinder, Steven E. Rokita, Daniel Boring, James A. Crowell, & Khosrow Kashfi. (2008). Abstract B109: Bioactivated chemotherapeutic agents based on ester-protected hydroxybenzyl phosphates (EHBP) for reversible alkylation of cellular nucleophiles. Cancer Prevention Research. 1(7_Supplement). B109–B109. 1 indexed citations
15.
Reid, Joel M., Sumithra J. Mandrekar, William S. Harmsen, et al.. (2008). Comparative Bioavailability of Sulindac in Capsule and Tablet Formulations. Cancer Epidemiology Biomarkers & Prevention. 17(3). 674–679. 11 indexed citations
16.
Boring, Daniel, et al.. (1999). Investigation of Structural Analogs of Prostaglandin Amides for Binding to and Activation of CB1 and CB2 Cannabinoid Receptors in Rat Brain and Human Tonsils. Advances in experimental medicine and biology. 469. 527–533. 34 indexed citations
17.
Boring, Daniel. (1997). The CDER Labeling and Nomenclature Committee: Structure, Function, and Process. Drug Information Journal. 31(1). 7–11. 7 indexed citations
18.
Boring, Daniel, et al.. (1991). Trifunctional agents as a design strategy for tailoring ligand properties: irreversible inhibitors of A1 adenosine receptors. Bioconjugate Chemistry. 2(2). 77–88. 15 indexed citations
19.
Boring, Daniel & Robert D. Sindelar. (1988). Organocuprate conjugate addition to 2,3-dihydro-4H-pyran-4-ones. The Journal of Organic Chemistry. 53(15). 3617–3621. 12 indexed citations
20.
Lemke, Thomas & Daniel Boring. (1980). Novel heterocycles. Synthesis of the 2,4,3‐benzodiazaphosphepine ring system. Journal of Heterocyclic Chemistry. 17(7). 1455–1456. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Carlos A. Velázquez‐Martínez Breakdown of academic impact, for papers by Giulia Nesi Breakdown of academic impact, for papers by L.J. Marnett Breakdown of academic impact, for papers by Chuan Ji Breakdown of academic impact, for papers by Thorsten J. Maier Breakdown of academic impact, for papers by Isabel Siegle Breakdown of academic impact, for papers by Michelle V. Williams Breakdown of academic impact, for papers by Xiaoming Xin Breakdown of academic impact, for papers by Marc Lecomte Breakdown of academic impact, for papers by Weijian Zhang
Rankless by CCL
2026